Can Spectral and Metra Save Each Other?
As young diagnostics companies struggle to survive, perhaps one of the most telling stories is that of Spectral Diagnostics Inc. and Metra Biosystems Inc. Once considered to be among the most promising start-ups of the crop that formed in the late 1980s and early 1990s, both companies have been struggling. Their proposed merger, announced in December, indicates just how ripe the diagnostics industry is for small-cap consolidation.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.